company

STIFTELSEN TIL DIABETESFORSKNING

Return on Equity
−13,3 %
Current Ratio
192,8
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue−744 000
Net Income−765 000
Total Assets5 784 000
Total Equity5 754 000
Income (NOK)2022
Revenue−744 000
Expenditure21 000
Operating Profit−765 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−765 000
Tax0
Net Income−765 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets5 784 000
Total Assets5 784 000
Total Retained Equity4 028 000
Total Equity5 754 000
Total Long-Term Debt0
Total Current Debt30 000
Total Equity and Debt5 784 000
Cash flow (NOK)2022
Sales Income0
Other Income−744 000
Revenue−744 000
Cost of Goods Sold0
Salary Costs16 000
Depreciation0
Impairment0
Expenditure21 000
Operating Profit−765 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−765 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments5 557 000
Cash, Bank227 000
Total Current Assets5 784 000
Total Assets5 784 000
Total Equity5 754 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt30 000
Total Current Debt30 000
Total Equity and Debt5 784 000
Financial indicators2022
Return on Equity−13,3 %
Debt-to-Equity Ratio0
Operating Profit Margin102,82 %
Current Ratio192,8
Quick Ratio192,8
Equity Ratio0,99
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English